TD
Translational Development Acquisition Corp.
TDAC · NASDAQ
$10.90 +0.00% (+$0.00)
1M +0.37%
Market Cap $268.5M
P/E Ratio 48.50x
Div. Yield -
ROE 3.28%
Piotroski F-Score Weak
3/9Valuation
32 /100
Expensive P/B 1.79x
P/E 48.50x
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
36 /100
Average ROA 3.52%
Asset turnover 0.00x
ROE 3.28%
Debt
0 /100
High Current ratio 0.06x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
5 /100
Unstable EPS volatility 1,558.73%
Profitable years 1
Beta 0.01x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TDAC
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City